Navigation Links
Updated HIV therapy guidelines would reduce risk of transmission, save lives, billions in costs
Date:6/7/2010

was based on the epidemic in B.C., which is concentrated among men who have sex with men and injection drug users. Most other parts of the world have generalized epidemics. Such differences should be taken into account when reviewing B.C.'s results in the context of the epidemic in other areas.

"HAART expansion based on the 2008 IAS-USA guidelines has tremendous potential to further improve health outcomes among HIV-infected individuals in B.C. and throughout the world," said Montaner. "Furthermore, under the BC-CfE's treatment as prevention program, expanding HAART coverage could substantially change the course of the HIV epidemic by decreasing rates of HIV transmission, tuberculosis, malaria and other infectious diseases and therefore curbing the growth of the HIV epidemic."

The HIV epidemic remains challenging. In 2008, an estimated 33 million individuals were living with HIV/AIDS in the world, approximately 2.7 million became HIV infected and two million died from AIDS-related causes.

The B.C. provincial government has invested $48 million over four years in a pilot project to expand HAART treatment called Seek and Treat. It will expand access to HIV/AIDS medications among hard-to-reach populations, including sex trade workers, injection drug users and men who have sex with men. By engaging more British Columbians living with HIV/AIDS in HAART, better care will be provided and the treatment will significantly reduce or eliminate the virus' ability to spread. B.C.'s Seek and Treat program is being evaluated as part of the BC-CfE's innovative research program, Seek and Treat for the Optimal Prevention of HIV/AIDS (STOP HIV/AIDS). STOP HIV/AIDS has received a US$2.5 million Avant Garde Award from the US National Institute of Drug Abuse (NIDA) of the National Institutes of Health.


'/>"/>

Contact: Graham Pollock
gpollock@cfenet.ubc.ca
604-806-9093
University of British Columbia
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Shoot 1UP, Popular Xbox 360 Action Game, Updated for Disabled Gamers
2. EAU launches new and updated clinical guidelines for 2010
3. Lawrence Berkeley National Laboratory and OpenHelixTM Announce an Updated Free Tutorial Suite for VISTA: Tools for Comparative Genomics
4. College of American Pathologists Releases New Updated CAP Electronic Cancer Checklist (CAP eCC)
5. Updated Fish Consumption Advisories Issued for 2010
6. NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy
7. Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkins Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data
8. Experimental targeted therapy shows early promise against medulloblastomas
9. Antibody therapy lengthens survival of metastatic melanoma patients in large clinical trial
10. Targeted Therapy Shows Promise Against Deadly Brain Cancer
11. Ft Myers Plastic Surgeon, Dr. Robert J. Brueck MD, Performs Facial Rejuvenation Using Innovative Stem Cell Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 ... will be holding a lupus ... on June 10th. , Meeting ... 6:30 p.m. – 8 p.m., ... from Sparrow Hospital),                  1200 ...
(Date:5/20/2013)... 20, 2013 yurbuds®, maker of the ... today announced the launch of its new Signature Series ... Jacobs, with more signature athletes to come. Created with ... Series ITE 100 is the perfect training partner for ... 100 features reflective, tangle-resistant Kevlar cords, premium sound quality ...
(Date:5/20/2013)... at Galveston researchers have been awarded a five-year, $1.8 ... and Stroke to apply the techniques of gene therapy ... pain that arises from a malfunction in the nervous ... for millions of Americans, manifesting itself in a variety ... feel intense discomfort in response to a light touch, ...
(Date:5/20/2013)... 20, 2013 Stemedica Cell ... stem cell manufacturing, research and development, announced today ... and Director of Interventional Cardiology Research at the ... Scientific and Medical Advisory Board for Stemedica’s Cardiology ... Dr. Wilensky divides his time between the cardiac ...
(Date:5/20/2013)... York (PRWEB) May 20, 2013 The nationwide ... study has found that magnetic resonance imaging (MRI) can be ... of whether or not patients are experiencing symptoms. According ... Journal of Bone & Joint Surgery, MRI detected synovitis (tissue ... patients suffering symptoms due to mechanical causes, the detection rate ...
Breaking Medicine News(10 mins):Health News:yurbuds Expands Best-Selling Lines with Innovative New Products 2Health News:Pain, pain, go away 2Health News:Pain, pain, go away 3Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 2Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 3Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 2Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 3Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 4
... by ticks , THURSDAY, Oct. 4 (HealthDay News) -- Many ... may actually have been bitten by another tick and have ... "It is striking how often re-infection appears to occur," lead ... York Medical College, said in a prepared statement. "Our findings ...
... Institute of Child Health and Human Development (NICHD) announced ... was awarded a competitive contract to participate in the ... be conducted in the United States to assess the ... human health. The study will follow 100,000 children from ...
... A 1998 settlement designed to limit the marketing of smokeless ... University of Georgia study published in the early online edition ... rates are significant and have been very stable over the ... the UGA Grady College of Journalism and Mass Communication. We ...
... Oct. 4 Nastech Pharmaceutical,Company Inc. (Nasdaq: ... "Rick",Costantino, Ph.D., to Chief Scientific Officer of Delivery. ... development of new,drug delivery technologies for peptide and ... since 2003, is retiring,tomorrow, October 5, 2007, as ...
... Energizer has forged a,national partnership with Susan ... its,encouraging message-the Power to Keep Going(R)-to more than ... (Photo: http://www.newscom.com/cgi-bin/prnh/20071004/AQTH013 ) Officials with ... a,special one. Energizer is the battery known around ...
... which a cell protein protects cancer cells,from a ... target for,improving treatment outcomes for patients., A team ... Medical Research (CCIA), led,by Associate Professor Maria Kavallaris, ... could play an important role in resistance to ...
Cached Medicine News:Health News:Lyme Disease Relapse Often a New Infection 2Health News:UMASS Medical School awarded National Children's Study contract 2Health News:UMASS Medical School awarded National Children's Study contract 3Health News:UMASS Medical School awarded National Children's Study contract 4Health News:UGA study: Youth exposed to smokeless tobacco ads despite settlement 2Health News:UGA study: Youth exposed to smokeless tobacco ads despite settlement 3Health News:Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery 2Health News:Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery 3Health News:Energizer Joins Roster of Susan G. Komen Race for the Cure(R) National Sponsors; Energizer(R) ReTreat Pampers Cancer Survivors With Traveling Mini-Spa 2Health News:Energizer Joins Roster of Susan G. Komen Race for the Cure(R) National Sponsors; Energizer(R) ReTreat Pampers Cancer Survivors With Traveling Mini-Spa 3Health News:Cell skeleton may hold key to overcoming drug resistance in cancer 2
(Date:5/20/2013)... VIEJO , Kalifornien, 20. Mai 2013 ... bekannt, dass das Unternehmen die CE-Kennzeichnung für ... zur Embolisation von Aneurysmen erhalten hat. Das ... Europa bereits mit der kontrollierten Einführung dieser ... bietet die SL-Produktfamilie auch ein verbessertes Handling, ...
(Date:5/20/2013)... 20, 2013  Atlantic Pharmaceuticals, Inc., a specialty ... a unique technology to deter prescription drug abuse ... Anthony Soscia , has been chosen ... Chronicle ,s Health-Care Heroes Awards. The awards are ... to honor individuals and organizations demonstrating excellence and ...
(Date:5/20/2013)... YORK , LONDON , ... , May 20, 2013 ... of Osteoarthritis and Preference for Minimally Invasive Procedures to ... landscape, and market trends for the six arthroscopy device ... (FMSs), arthroscopy implants, arthroscopy radio frequency systems, and arthroscopy ...
Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4
... Oct. 29 Stryker Corporation (NYSE: SYK ... a division of Porex Corporation. Porex Surgical is a ... (PPE) for use primarily in reconstructive surgery of the ... the PPE market with strong brand recognition and considerable ...
... LEIDEN, Netherlands, Oct. 29 Pursuant to the provisions of ... Takeover Bids (Besluit Openbare Biedingen Wft) requiring a public announcement ... offer to provide a status update, Johnson & Johnson (NYSE: ... CRXL ; Swiss Exchange: CRX) provide the following ...
Cached Medicine Technology:Stryker Announces Acquisition of Privately-Held Porex Surgical 2Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 2Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 3Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 4Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 5
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
... Used for catheter positioning and exchange ... of the wire guide coils allows utilization ... a smooth transition to a very flexible ... guide is the most rigid coiled wire ...
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: